DDG-39
DDG-39 is a cytosine nucleoside analogue demonstrating potent and selective antiviral activity against HIV-1 and HBV in vitro, with an average IC50 of 0.61 μM. It serves as a research tool for investigating antiviral mechanisms and nucleoside analogue therapies in cell-based assays.
Product Specifications
CAS Number
119555-47-4
Product Name Alternative
HIVProtease, HIV Protease, HIV-1, HBV, DDG39, DDG-39, DDG 39, 1- (2,3-dideoxy-2-fluoropentofuranosyl) cytosine, Antiviral
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Protein Biochemistry
Purity
99.17% (May vary between batches)
Smiles
F[C@@H]1[C@@H] (O[C@H] (CO) C1) N2C (=O) N=C (N) C=C2
Molecular Formula
C9H12FN3O3
Molecular Weight
229.21
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1231562-01 0.02 mg (E-Coli)
Recombinant Brucella suis Homoserine kinase (thrB)
Sign In for Pricing
View Details MBS1231562-02 0.02 mg (Yeast)
Recombinant Brucella suis Homoserine kinase (thrB)
Sign In for Pricing
View Details